BNR is Burning Rock Biotech Limited (Healthcare) — a non-dividend-paying stock. Trading at $11.99. Market cap: $114M. Capital Quality Rank: 32/100 — Stagnant mediocrity.
Stock snapshot
| Price | $11.99 |
| Market cap | $114M |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 32 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -74.0% |
| Revenue CAGR (3y) | -1.9% |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Distress |
About BNR
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Related non-dividend companies
Other non-dividend stocks investors research alongside BNR. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is BNR's current stock price?
BNR (Burning Rock Biotech Limited) is currently trading at $11.99.
Does BNR pay a dividend?
BNR (Burning Rock Biotech Limited) does not currently pay a regular dividend.
What is BNR's Capital Quality Rank?
BNR has a Capital Quality Rank of 32/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track BNR in DiviDrip
Add BNR to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search BNR and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.